RARE vs WEYS · rev $350.0M vs P/E 15, rev $130.2M
Ultragenyx (RARE) versus Weyco Group Inc (WEYS) — a side-by-side from cached financials, not a winner call.
Ultragenyx (RARE) is a biotechnology company listed on US.
Weyco Group Inc (WEYS) is a footwear & accessories company listed on NASDAQ.
Latest reported RARE revenue for 2026-06-30 was $350.0M. Net income was -$277.0M. RARE currently screens at market cap $2.79B.
Latest reported WEYS revenue for 2026-06-30 was $130.2M. Net income was $19.4M. Revenue was up 91.5% from 2026-03-31 to 2026-06-30. WEYS currently screens at market cap $344.4M and trailing P/E 14.6.
RARE currently screens at market cap $2.79B. WEYS currently screens at market cap $344.4M and trailing P/E 14.6.
Not investment advice. Open the RARE and WEYS stock pages for the full models.
Not investment advice.